U.S., June 26 -- ClinicalTrials.gov registry received information related to the study (NCT07668505) titled 'Anti-inflammation Treatment for Idiopathic Inflammatory Myopathies' on June 22.
Brief Summary: The goal of this clinical trial is to learn if the drug Maraviroc works to treat refractory idiopathic inflammatory myopathy (myositis) in patients who have not responded well to traditional therapies. It will also learn about how the drug affects muscle inflammation and function.
The main questions it aims to answer are:
Does Maraviroc reduce inflammation in the muscles?
Does Maraviroc improve patients' muscle function and overall clinical symptoms?
This is an open-label study, meaning researchers will give Maraviroc to all participan...